Fundz

Fundz Deep Dive

Everything you need to win Aptose Biosciences — in one platform.

Who to reach, what to say, and why now on Aptose Biosciences — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Aptose Biosciences — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Aptose Biosciences and Hanmi Pharmaceutical Extend Loan Agreement for US$11.9 Million to Develop Tuspetinib for AML Treatment.

Sep 22, 2025•9 months ago

Contract Type

agreement

San DiegoBiotechnologyHealth CareMedicalTherapeuticsresearch

Description

Aptose Biosciences Inc. has entered into an amended US$11.9 million loan Facility Agreement with Hanmi Pharmaceutical Co. Ltd. to support the development of its tuspetinib-based therapy for acute myeloid leukemia

Company Information

Company

Aptose Biosciences

Location

12770 High Bluff Dr

San Diego, California, United States

About

Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address unmet clinical need in multiple hematologic malignancies.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Aptose Biosciences's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.